I think that C-Path is interesting, but it is not well validated at present. It is also not clear how to use the results to plan treatment.
HER2 status is your ideal marker of risk because it gives information about prognosis AND how to treat (give herceptin). A bad stroma score or whatever you want to call it on C-Path doesn't necessarily tell you what to do about it. I would say that C-Path would add little to your wife's care if the cancer is HER2 positive, as treatment in this case is usually indicated.
I think that C-Path is interesting, but it is not well validated at present. It is also not clear how to use the results to plan treatment.
HER2 status is your ideal marker of risk because it gives information about prognosis AND how to treat (give herceptin). A bad stroma score or whatever you want to call it on C-Path doesn't necessarily tell you what to do about it. I would say that C-Path would add little to your wife's care if the cancer is HER2 positive, as treatment in this case is usually indicated.